Understanding OR2H1 and OR2H2: Potential Drug Targets (G26716)
Understanding OR2H1 and OR2H2: Potential Drug Targets
Olfactory receptor family 2 (OR2H) is a family of olfactory receptors, which plays a crucial role in human sensory function. OR2H1 is a subfamily of OR2H that is involved in the sense of smell. This subfamily consists of two genes, OR2H1 and OR2H2 , which encode for the protein Olfactory receptor 1 (OR1) and OR2H1, respectively.
OR2H1 is a transmembrane protein that is expressed in the sensory epithelial cells of the nose and mouth. It is a G protein-coupled receptor (GPCR), which means that it uses the protein transmembrane domain to interact with intracellular signaling molecules. OR2H1 is involved in the detection of volatile organic compounds (VOCs), which are molecules that are emitted by volatile glands in the nose and mouth.
OR2H1 is a key receptor for the neurotransmitter oxytocin (OT), which is a hormone that is involved in social bonding, trust, and other physiological processes. Studies have shown that OR2H1 is involved in the regulation of behavioral responses to oxytocin, such as increased social interaction and reduced anxiety.
OR2H1 is also involved in the sense of taste. Taste is the sense that we use to detect the chemical properties of food and water. OR2H1 is expressed in taste epithelial cells and is involved in the detection of sweet and sour tastes.
OR2H2 is a cytoplasmic protein that is involved in the regulation of cell signaling processes. It is a GPCR and is expressed in various cell types, including sensory epithelial cells, pericytes, and the endothelium. OR2H2 is involved in the regulation of ion channels, which are responsible for the flow of electrical signals through cells.
OR2H2 is also involved in the regulation of cell signaling processes related to pain and inflammation. Studies have shown that OR2H2 is involved in the regulation of pain perception and the production of inflammatory cytokines.
Despite the involvement of OR2H1 and OR2H2 in various physiological processes, they are not yet considered drug targets. However, their potential role in drug development is under investigation.
The development of new drugs for the treatment of diseases associated with the Olfactory receptor family 2 (OR2H) is an attractive field of research. OR2H1 and OR2H2 are involved in various physiological processes, including sensory function and cell signaling, which makes them potential drug targets.
One of the challenges in developing new drugs for OR2H1 and OR2H2 is their complex structure. OR2H1 and OR2H2 are expressed in various cell types and their expression is regulated by various signaling pathways. This makes it difficult to predict the efficacy and safety of new drugs.
Another challenge is the lack of research on OR2H1 and OR2H2 in human disease. While there are some studies on the role of OR2H1 and OR2H2 in various diseases, such as cancer and neurodegenerative diseases, more research is needed to understand their role in human disease.
In conclusion, Olfactory receptor family 2 (OR2H) is a family of GPCR that is involved in various physiological processes, including sensory function and cell signaling. OR2H1 and OR2H2 are important genes that are involved in the sense of smell and taste. While they are not yet considered drug targets, their potential role in drug development is under investigation. Further research is needed to understand the complex structure of OR2H1 and OR2H2 and their role in human disease.
Protein Name: Olfactory Receptor Family 2 Subfamily H Member 1
Functions: Odorant receptor
The "OR2H1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2H1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P
